Drug Testing

For overweight consumers looking to lose weight fast, the use of lap band surgery as a quick and easy way to a new life can be tempting. But in some cases, it's deadly....

Eli Lilly and Co. is pouring more money than ever into its research and development pipeline, but Wall Street has been rewarding companies that cut such spending, according to a recent report by...

The head of the Food and Drug Administration's medical device unit stopped in San Diego last week for a series of one-on-one meetings with some of the area's largest device makers, including ResMed...

Last January Marc Alessi was tapped to lead the Long Island Angel Network as it sought to help finance startups that would hopefully grow to become the region's largest corporations. Now he has...

The natural dissipation of blood-alcohol evidence did not constitute an exigent circumstance justifying the warrantless taking of a blood sample from a drunk driver, the Missouri Supreme Court has ruled in affirming a...

Stony Brook University has entered into a multiyear research partnership with the global pharmaceutical company Sanofi to develop a potential treatment for tuberculosis and other bacterial infections. The university didn't disclose the terms...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/9c9628/strategies_for_eff) has announced the addition of the "Strategies for Effective Partnerships Between Pharmaceutical and Diagnostic Companies" report to their offering. This report from Business Insights examines the various...

ROCKVILLE, Md. -- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing oncology and CNS therapeutics, today announced that it has secured Hungarian Regulatory Authority and Ethics Committee...

SHEFFIELD, England -- Simcyp Limited, the leader in modelling and simulation of drug-drug interactions in virtual human populations, today announces it has extended its animal models to include a virtual mouse. Laboratory mice...

Net sales increase 9.6% to first quarter record $2.248 million; Net income up 30.9% to $755,000 LANCASTER, Calif. -- Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for...

NEWTOWN, Pa. -- Quotient Biodiagnostics, Inc. (Quotient), a supplier of innovative and high-quality transfusion diagnostic products to hospitals, blood banks and other healthcare institutions, is pleased to announce that its range of ALBAcyte[R]...

MDx Customers Realize Average Cash Improvements of More Than 25 Percent, Bad Debt Reductions of 50 Percent SAN DIEGO -- XIFIN Inc., the company revolutionizing revenue cycle management for diagnostic service providers, announced...

WILMINGTON, N.C. -- AAIPharma Services Corp. ("AAIPharma"), a leading provider of pharmaceutical product development services, announced today that it has appointed Eduardo Uribe to senior director of quality services at the company's Charleston,...

NEEDHAM, Mass. -- Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that dosing has initiated in a Phase 1 study of its hematopoietic growth factor, CDX-301, in healthy subjects. The study is being conducted...

WOBURN, Mass. -- ArQule, Inc. (NASDAQ: ARQL) today announced that treatment with tivantinib as single agent therapy produced a statistically significant 56 percent improvement in time-to-progression (TTP) in the intent-to-treat (ITT) population, the...

ROCKVILLE, Md. -- Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing oncology and CNS therapeutics, today provided guidance on its key pipeline, scientific and business goals for 2012. "Rexahn...

Bionime will offer innovative GE-branded clinical and home-based patient care products for the rapidly growing global diabetes population ALBANY, N.Y. & MILWAUKEE -- GE (NYSE: GE) today announced it has entered into a...

Call it Lilly's squeeze play. Indianapolis-based Eli Lilly and Co. is now in the predicament of watching revenue fall as its patents on older products expire, even as the company needs to spend...

San Diego-based startup Elevation Pharmaceuticals Inc. has raised $32 million in a second round of financing that will help the company advance its lead product candidate, an aerosol therapy for people with chronic...